364 related articles for article (PubMed ID: 18540933)
41. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
42. Validation of a screening questionnaire for androgen deficiency in aging males.
Morley JE; Charlton E; Patrick P; Kaiser FE; Cadeau P; McCready D; Perry HM
Metabolism; 2000 Sep; 49(9):1239-42. PubMed ID: 11016912
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
44. Testosterone replacement therapy for the primary care physician.
Casey RW; Barkin J
Can J Urol; 2008 Aug; 15 Suppl 1():71-7; discussion 77. PubMed ID: 18700068
[TBL] [Abstract][Full Text] [Related]
45. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
[TBL] [Abstract][Full Text] [Related]
46. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study.
Kalinchenko S; Vishnevskiy EL; Koval AN; Mskhalaya GJ; Saad F
Aging Male; 2008 Jun; 11(2):57-61. PubMed ID: 18570056
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of androgen deficiency in men with erectile dysfunction.
Köhler TS; Kim J; Feia K; Bodie J; Johnson N; Makhlouf A; Monga M
Urology; 2008 Apr; 71(4):693-7. PubMed ID: 18313109
[TBL] [Abstract][Full Text] [Related]
48. Testosterone replacement in older men and women.
Morley JE
J Gend Specif Med; 2001; 4(2):49-53. PubMed ID: 11480098
[TBL] [Abstract][Full Text] [Related]
49. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
[TBL] [Abstract][Full Text] [Related]
50. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry.
Morales A
BJU Int; 2011 May; 107(9):1369-73. PubMed ID: 21518230
[TBL] [Abstract][Full Text] [Related]
51. 'What should I do with a 60-year old man with a slightly low serum total testosterone concentration and normal levels of serum gonadotrophins'?
Hugh Jones T
Clin Endocrinol (Oxf); 2010 May; 72(5):584-8. PubMed ID: 19878210
[TBL] [Abstract][Full Text] [Related]
52. Prostate cancer following testosterone replacement in Klinefelter syndrome.
Bydder SA; Joseph DJ; Weinstein S; Stuckey BG
ANZ J Surg; 2007; 77(1-2):93-4. PubMed ID: 17295832
[TBL] [Abstract][Full Text] [Related]
53. Association between the androgen levels and erectile function, cognitive functions and hypogonadism symptoms in aging males.
Kocoglu H; Alan C; Soydan H; Ateş F; Adayener C; Eren AE; Ersay AR; Dayanc M
Aging Male; 2011 Dec; 14(4):207-12. PubMed ID: 22066788
[TBL] [Abstract][Full Text] [Related]
54. Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry.
Morales A; Spevack M; Emerson L; Kuzmarov I; Casey R; Black A; Tremblay R
Aging Male; 2007 Jun; 10(2):57-65. PubMed ID: 17558969
[TBL] [Abstract][Full Text] [Related]
55. Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency.
Park NC; Yan BQ; Chung JM; Lee KM
Aging Male; 2003 Jun; 6(2):86-93. PubMed ID: 12898792
[TBL] [Abstract][Full Text] [Related]
56. [Testosterone and impotence--when is androgen substitution advisable?].
John H
Ther Umsch; 1998 Jun; 55(6):372-6. PubMed ID: 9658979
[TBL] [Abstract][Full Text] [Related]
57. [65-month testosterone replacement therapy for androgen deficiency-induced ED: a case report and review of the literature].
Jiang T; Zheng L; Sun DC; Li QL; Zhang ZW; Wang FP; Wang QF; Jiang H
Zhonghua Nan Ke Xue; 2014 Feb; 20(2):152-5. PubMed ID: 24520668
[TBL] [Abstract][Full Text] [Related]
58. Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
Satoh T; Ishiyama H; Matsumoto K; Tsumura H; Kitano M; Hayakawa K; Ebara S; Nasu Y; Kumon H; Kanazawa S; Miki K; Egawa S; Aoki M; Toya K; Yorozu A; Nagata H; Saito S; Baba S
BJU Int; 2009 Apr; 103(8):1064-8. PubMed ID: 19040526
[TBL] [Abstract][Full Text] [Related]
59. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism.
Karazindiyanoğlu S; Cayan S
Aging Male; 2008 Sep; 11(3):146-9. PubMed ID: 18821291
[TBL] [Abstract][Full Text] [Related]
60. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
Miner MM; Seftel AD
Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
